Hunan Hansen Pharmaceutical Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Hansen Pharmaceutical Company Limited with three other
companies in this sector in China:
Jilin Jian Yisheng Pharmaceutical Company Limited
sales of 819.51 million Chinese Renmimbi [US$121.11 million]
of which 81%
Nantong Jinghua Pharmaceutical Co Ltd
(780.18 million Chinese Renmimbi [US$115.29 million]
of which 28%
was Chinese Drugs Pharmaceutics), and
Yantai Dongcheng Pharmaceutical Group Co Ltd
(794.92 million Chinese Renmimbi [US$117.47 million]
of which 100%
was Pharmaceutical Industry).
Hunan Hansen Pharmaceutical Company Limited reported sales of 781.01 million Chinese Renmimbi (US$115.42 million)
December of 2015.
increase of 5.9%
versus 2014, when the company's sales were 737.38 million Chinese Renmimbi.
Sales at Hunan Hansen Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 127%).
Sales of Medical Industry saw an increase
6.0% in 2015, from
736.82 million Chinese Renmimbi to 780.83 million Chinese Renmimbi.
Not all segments of Hunan Hansen Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Others fell 51.0% to 297,205.54 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).